大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/27 | 2,152 | 2,183 | 2,111 | 2,170 | -12 | -0.5% | 453,000 |
2020/07/22 | 2,191 | 2,199 | 2,144 | 2,182 | ±0 | ±0% | 372,600 |
2020/07/21 | 2,151 | 2,182 | 2,147 | 2,182 | +32 | +1.5% | 267,900 |
2020/07/20 | 2,136 | 2,208 | 2,131 | 2,150 | -12 | -0.6% | 367,700 |
2020/07/17 | 2,205 | 2,214 | 2,131 | 2,162 | -46 | -2.1% | 611,700 |
2020/07/16 | 2,249 | 2,267 | 2,202 | 2,208 | -27 | -1.2% | 430,400 |
2020/07/15 | 2,256 | 2,270 | 2,192 | 2,235 | -18 | -0.8% | 395,500 |
2020/07/14 | 2,270 | 2,354 | 2,230 | 2,253 | -31 | -1.4% | 651,700 |
2020/07/13 | 2,237 | 2,297 | 2,175 | 2,284 | +82 | +3.7% | 613,000 |
2020/07/10 | 2,221 | 2,284 | 2,199 | 2,202 | -4 | -0.2% | 508,900 |
2020/07/09 | 2,266 | 2,287 | 2,185 | 2,206 | -60 | -2.6% | 681,400 |
2020/07/08 | 2,320 | 2,363 | 2,250 | 2,266 | -58 | -2.5% | 622,900 |
2020/07/07 | 2,371 | 2,403 | 2,285 | 2,324 | -75 | -3.1% | 688,000 |
2020/07/06 | 2,478 | 2,478 | 2,390 | 2,399 | -78 | -3.1% | 736,700 |
2020/07/03 | 2,450 | 2,484 | 2,390 | 2,477 | +34 | +1.4% | 408,100 |
2020/07/02 | 2,529 | 2,554 | 2,358 | 2,443 | -84 | -3.3% | 942,200 |
2020/07/01 | 2,624 | 2,637 | 2,513 | 2,527 | -73 | -2.8% | 490,700 |
2020/06/30 | 2,632 | 2,643 | 2,536 | 2,600 | -26 | -1% | 780,100 |
2020/06/29 | 2,594 | 2,681 | 2,576 | 2,626 | +23 | +0.9% | 829,500 |
2020/06/26 | 2,608 | 2,619 | 2,535 | 2,603 | -3 | -0.1% | 552,000 |
2020/06/25 | 2,590 | 2,653 | 2,570 | 2,606 | -2 | -0.1% | 664,600 |
2020/06/24 | 2,500 | 2,630 | 2,487 | 2,608 | +91 | +3.6% | 873,200 |
2020/06/23 | 2,546 | 2,546 | 2,456 | 2,517 | -4 | -0.2% | 477,800 |
2020/06/22 | 2,458 | 2,552 | 2,450 | 2,521 | +59 | +2.4% | 722,300 |
2020/06/19 | 2,487 | 2,508 | 2,426 | 2,462 | -16 | -0.6% | 613,300 |
2020/06/18 | 2,465 | 2,520 | 2,433 | 2,478 | +15 | +0.6% | 603,700 |
2020/06/17 | 2,379 | 2,505 | 2,352 | 2,463 | +86 | +3.6% | 1,241,300 |
2020/06/16 | 2,222 | 2,385 | 2,211 | 2,377 | +182 | +8.3% | 1,075,500 |
2020/06/15 | 2,250 | 2,276 | 2,193 | 2,195 | -55 | -2.4% | 643,700 |
2020/06/12 | 2,130 | 2,254 | 2,120 | 2,250 | +58 | +2.6% | 770,200 |
2020/06/11 | 2,265 | 2,277 | 2,172 | 2,192 | -40 | -1.8% | 487,900 |
2020/06/10 | 2,220 | 2,264 | 2,215 | 2,232 | -6 | -0.3% | 497,900 |
2020/06/09 | 2,185 | 2,249 | 2,120 | 2,238 | +31 | +1.4% | 790,400 |
2020/06/08 | 2,291 | 2,297 | 2,199 | 2,207 | -107 | -4.6% | 1,039,700 |
2020/06/05 | 2,354 | 2,366 | 2,271 | 2,314 | -61 | -2.6% | 809,800 |
2020/06/04 | 2,320 | 2,378 | 2,290 | 2,375 | +21 | +0.9% | 762,700 |
2020/06/03 | 2,288 | 2,354 | 2,283 | 2,354 | +96 | +4.3% | 1,129,200 |
2020/06/02 | 2,191 | 2,284 | 2,175 | 2,258 | +36 | +1.6% | 1,125,300 |
2020/06/01 | 2,149 | 2,256 | 2,114 | 2,222 | -25 | -1.1% | 2,057,000 |
2020/05/29 | 1,930 | 2,250 | 1,928 | 2,247 | +317 | +16.4% | 5,086,300 |
2020/05/28 | 1,877 | 1,938 | 1,862 | 1,930 | +90 | +4.9% | 1,235,200 |
2020/05/27 | 1,762 | 1,863 | 1,735 | 1,840 | +71 | +4% | 963,700 |
2020/05/26 | 1,842 | 1,844 | 1,732 | 1,769 | -66 | -3.6% | 1,247,200 |
2020/05/25 | 1,847 | 1,850 | 1,782 | 1,835 | -18 | -1% | 778,800 |
2020/05/22 | 1,880 | 1,894 | 1,845 | 1,853 | -27 | -1.4% | 529,300 |
2020/05/21 | 1,873 | 1,886 | 1,836 | 1,880 | +2 | +0.1% | 557,700 |
2020/05/20 | 1,881 | 1,915 | 1,855 | 1,878 | +11 | +0.6% | 683,200 |
2020/05/19 | 1,940 | 1,940 | 1,821 | 1,867 | -86 | -4.4% | 1,275,600 |
2020/05/18 | 1,923 | 1,963 | 1,895 | 1,953 | +29 | +1.5% | 997,900 |
2020/05/15 | 1,811 | 1,931 | 1,811 | 1,924 | +104 | +5.7% | 1,544,800 |
1201~
1250
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
CANBAS | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム